chr1-231693919-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_018662.3(DISC1):āc.161T>Gā(p.Ile54Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000109 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 33)
Exomes š: 0.000011 ( 0 hom. )
Consequence
DISC1
NM_018662.3 missense
NM_018662.3 missense
Scores
1
8
10
Clinical Significance
Conservation
PhyloP100: 0.996
Genes affected
DISC1 (HGNC:2888): (DISC1 scaffold protein) This gene encodes a protein with multiple coiled coil motifs which is located in the nucleus, cytoplasm and mitochondria. The protein is involved in neurite outgrowth and cortical development through its interaction with other proteins. This gene is disrupted in a t(1;11)(q42.1;q14.3) translocation which segregates with schizophrenia and related psychiatric disorders in a large Scottish family. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
TSNAX-DISC1 (HGNC:49177): (TSNAX-DISC1 readthrough (NMD candidate)) This gene represents naturally occurring read-through transcription between the neighboring TSNAX (translin-associated factor X) and DISC1 (disrupted in schizophrenia 1) genes on chromosome 1. Alternative splicing results in multiple transcript variants, all of which are candidates for nonsense-mediated mRNA decay (NMD) and are unlikely to be protein-coding. These alterations in gene processing may be associated with risk for psychiatric illness, most notably, schizophrenia. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.28783643).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DISC1 | NM_018662.3 | c.161T>G | p.Ile54Ser | missense_variant | 2/13 | ENST00000439617.8 | NP_061132.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DISC1 | ENST00000439617.8 | c.161T>G | p.Ile54Ser | missense_variant | 2/13 | 5 | NM_018662.3 | ENSP00000403888.4 | ||
DISC1 | ENST00000366637.8 | c.161T>G | p.Ile54Ser | missense_variant | 2/13 | 5 | ENSP00000355597.6 | |||
TSNAX-DISC1 | ENST00000602956.5 | n.*22T>G | non_coding_transcript_exon_variant | 6/13 | 2 | ENSP00000473532.1 | ||||
TSNAX-DISC1 | ENST00000602956.5 | n.*22T>G | 3_prime_UTR_variant | 6/13 | 2 | ENSP00000473532.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248842Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134740
GnomAD3 exomes
AF:
AC:
1
AN:
248842
Hom.:
AF XY:
AC XY:
1
AN XY:
134740
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461874Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 727240
GnomAD4 exome
AF:
AC:
16
AN:
1461874
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
727240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.161T>G (p.I54S) alteration is located in exon 2 (coding exon 2) of the DISC1 gene. This alteration results from a T to G substitution at nucleotide position 161, causing the isoleucine (I) at amino acid position 54 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;.;.;.;.;.;.;.;T;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;M;.;M;M;M;M;.;.;M;M
MutationTaster
Benign
N;N;N;N;N;N;N;N;N;N;N
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;N;.;N;D;N;.;N;N;.;.;N;.
REVEL
Benign
Sift
Uncertain
D;D;.;.;D;D;.;D;D;.;.;D;.
Sift4G
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;.
Polyphen
D;.;.;.;D;D;.;.;D;.;.;D;.
Vest4
MutPred
Gain of glycosylation at I54 (P = 0.0011);Gain of glycosylation at I54 (P = 0.0011);Gain of glycosylation at I54 (P = 0.0011);Gain of glycosylation at I54 (P = 0.0011);Gain of glycosylation at I54 (P = 0.0011);Gain of glycosylation at I54 (P = 0.0011);Gain of glycosylation at I54 (P = 0.0011);Gain of glycosylation at I54 (P = 0.0011);Gain of glycosylation at I54 (P = 0.0011);Gain of glycosylation at I54 (P = 0.0011);Gain of glycosylation at I54 (P = 0.0011);Gain of glycosylation at I54 (P = 0.0011);Gain of glycosylation at I54 (P = 0.0011);
MVP
MPC
0.64
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at